Prenetics
Edit

Prenetics

http://prenetics.com/
Last activity: 05.03.2025
Active
Categories: BioTechCareDiagnosticsDrugHealthTechInformationLEDLifePersonalTechnology
Prenetics is a technology driven life sciences company specializing in precision medicine and digital health. Prenetics has developed iGenes, a non-invasive test which identifies in every patient the right drug and right dosage based on an individual's unique DNA. In addition, Prenetics has also launched myDNA, a lifestyle and wellness test which provides users with the most optimal diet and nutrition.

At Prenetics, our mission is to help people lead healthier, more active lives by empowering them with predictive and preventive treatments using the latest proven innovations in DNA technology.

Our team consists of top-tier scientists, engineers and healthcare professionals who work together to provide vital information to physicians.

We use advanced DNA Sequencing technology with custom automation in our ISO-accredited diagnostics laboratory. Accreditation: ISO15189:2012. EQAP: CAP, WHO, QCMD.

Many years of research and development now pave the way for Prenetics to make a difference to society. For more information, please visit www://www.prenetics.com
Likes
48.4K
Followers
577
Website visits
9.6K /mo.
Mentions
76
Location: China, Hong Kong, Hong Kong Island
Employees: 501-1000
Phone: +852 2210 9588
Total raised: $82.65M
Founded date: 2009

Investors 5

Funding Rounds 4

DateSeriesAmountInvestors
15.10.2024-$30MTencent
17.10.2017-$40M-
16.03.2016Series A$10MPing An Ve...
03.12.2014Seed$2.65M-

Mentions in press and media 76

DateTitleDescription
07.03.2025The Digital Frontier: Tencent Cloud and Trident's Metaverse LeapIn the fast-paced world of technology, partnerships can be the spark that ignites innovation. Tencent Cloud and Trident Digital Tech Holdings Ltd have joined forces, setting the stage for a digital revolution. This collaboration is not just...
05.03.2025Prenetics Announces Fourth Quarter and Full Year 2024 Financial Results, Provides 2025 GuidanceRevenue grew 93.5% to $10.5 million in the fourth quarter and 40.9% year-over-year to $30.6 million in 2024 Cash and short-term assets of $84.8 million as of December 31, 2024 Provides first quarter and full year 2025 guidance Projects full...
21.12.2024The Future of Health: Bridging Science and Technology for Better WellnessIn the evolving landscape of health and wellness, two companies are making waves: Prenetics' IM8 and Ubie. Both are leveraging cutting-edge technology and partnerships to redefine how we approach health. Their recent initiatives highlight a...
19.12.2024Prenetics' IM8 Announces Collaboration with Mayo Clinic to Develop New Line of Premium SupplementsCollaboration to Focus on Nutrition, Cellular Rejuvenation, Protein, Collagen and Overall Wellness IM8, a New Premium Supplements Brand, Launched Officially on November 18th on IM8health.com CHARLOTTE, N.C., Dec. 19, 2024 /PRNewswire/ -- Pr...
27.11.2024Prenetics Announces Third Quarter 2024 Financial ResultsRevenue Grew 59.4% to $7.8 million from Prior Year and 30.9% Sequentially Officially Launched IM8Health.com, a new premium supplements brand Tencent Invests $30 million in Insighta's Early Cancer Detection Reiterates Revenue Target to Excee...
18.11.2024Nasdaq-Listed Prenetics and David Beckham Officially Launch IM8 HealthBeckham is a strategic investor in Prenetics and Co-Founding Partner for IM8 IM8 launch marks a bold entry into the $187 billion global consumer health market Launch follows recently announced Prenetics' acquisition of Europa, one of the la...
16.10.2024Tencent's $30 Million Bet on Insighta: A New Dawn for Cancer DetectionIn a world where early detection can mean the difference between life and death, Prenetics Global Limited has taken a bold step forward. The health sciences company recently announced a significant investment from Tencent, a tech giant, amo...
15.10.2024Prenetics Announces Tencent's US$30 Million Investment in Insighta, Strengthening Strategic Partnership for AI-Driven Early Cancer DetectionHONG KONG, Oct. 15, 2024 /PRNewswire/ -- Prenetics Global Limited (NASDAQ: PRE), a leading health sciences company, today announced that Tencent has made a strategic US$30 million investment in Insighta, a Hong Kong-based early cancer detec...
15.10.2024Prenetics Announces Tencent’s US$30 Million Investment in Insighta, Strengthening Strategic Partnership for AI-Driven Early Cancer DetectionHONG KONG, Oct. 15, 2024 (GLOBE NEWSWIRE) -- Prenetics Global Limited (NASDAQ: PRE), a leading health sciences company, today announced that Tencent has made a strategic US$30 million investment in Insighta, a Hong Kong-based early cancer d...
07.10.2024Prenetics Announces Second Quarter 2024 Financial ResultsCost Optimization Boosted Gross Margin by 21.7% YoY in H1 2024 Enters U.S. Health Market in October with IM8, a New Health and Wellness brand Re-affirms Revenue Target to Exceed US$33 million for FY 2024 CHARLOTTE, N.C., Oct. 7, 2024 /PRNew...
Show more

Reviews 0

Sign up to leave a review

Sign up Log In